All updates
All updates
today 39中文产业新闻Chinese source评分6565 中文产业新闻Chinese source评分6060 三星生物$21.7亿配股筹资并购PolyPeptide
文献与产业新闻评分1111 CDMO Lonza hones commercial focus with company vet's return to new role
文献与产业新闻评分2828 Electra aims to light up Nasdaq with IPO for phase 2/3 I&I push
文献与产业新闻评分2222 B. Braun adds to a string of IV solution recalls in US
文献与产业新闻评分5151 Eli Lilly inks $2.88B Merida buyout for autoimmune drugs against rogue antibodies
文献与产业新闻评分2626 Natera teams with Angiex on cancer drug trial monitoring
文献与产业新闻评分4040 Trans-Pacific AusperBio draws $120M to advance ASO for chronic HBV: Finance Report
文献与产业新闻评分1111 STAT+: Up and down the ladder: The latest comings and goings
中文产业新闻精选Chinese source评分7272 映恩生物与罗氏达成超10亿美元ADC合作，首付款4500万美元
中文产业新闻Chinese source评分6666 映恩生物与基因泰克达成10.45亿美元ADC合作协议
中文产业新闻Chinese source评分6464 AusperBio完成1.2亿美元C轮融资，推进AHB-137 III期临床与商业化
中文产业新闻精选Chinese source评分7171 基因泰克引进映恩生物DUPAC™平台 合作开发下一代ADC
中文产业新闻精选Chinese source评分7777 映恩生物与基因泰克就DUPAC™ ADC平台达成超10亿美元全球许可合作
中文产业新闻精选Chinese source评分7171 映恩生物与罗氏旗下基因泰克达成超 10 亿美元 ADC 全球合作
中文产业新闻精选Chinese source评分7171 映恩生物与基因泰克达成全球合作，基于DUPAC™平台共同开发下一代ADC
中文产业新闻Chinese source评分6161 浩博医药完成1.2亿美元C轮融资，RA Capital新进，以ASO+siRNA双平台攻乙肝功能性治愈
中文产业新闻Chinese source评分6565 映恩生物与Genentech达成超10亿美元ADC全球独家许可合作
中文产业新闻精选Chinese source评分6969 映恩生物与罗氏就新毒素ADC平台DUPAC达成超10亿美元合作
中文产业新闻Chinese source评分6464 罗氏与映恩生物就DUPAC ADC平台达成超10亿美元合作
中文产业新闻Chinese source评分6565 与罗氏基因泰克达成DUPAC平台ADC合作，映恩生物全球累计交易额超60亿美元
中文产业新闻Chinese source评分6060 浩博医药完成1.2亿美元C轮融资，推进AHB-137 III期及乙肝疗法布局
文献与产业新闻评分3838 AusperBio adds $120M series C to advance hep B oligo therapy through phase 3 and beyond
文献与产业新闻评分4444 Teva saddles up as stalking horse bidder for bankrupt BioXcel’s neuroscience portfolio
文献与产业新闻评分1010 Biogen enlists lupus patient advocate to share social media story of resilience
文献与产业新闻评分77 Omnicom PR consultancy injects new leadership into pharma push
文献与产业新闻精选评分5757 Genentech doubles down on ADC-resistant cancers with $1B DualityBio pact
文献与产业新闻评分3333 Kynexis: Lowering kynurenic acid levels to improve cognitive function
文献与产业新闻评分1414 Fierce Pharma Asia—Roche’s $2.5B obesity deal; Akeso CEO’s defense; Lawmaker’s reflection on China
文献与产业新闻评分2626 BMS splashes out $173M to build 2nd radiopharmaceutical plant in Indiana
文献与产业新闻评分1313 Chutes & Ladders—Vivace revs up C-suite ahead of pivotal push
中文产业新闻Chinese source评分6161 SK Biopharmaceuticals以最高7.95亿美元获Biohaven癫痫新药Opakalim全球权益，目标2029年美国上市
文献与产业新闻评分2020 As RevMed preps for ‘historic’ pancreatic cancer launch, questions linger on the ground
文献与产业新闻评分4848 CEPI backs push to bring Egyptian biotech's Ebola vaccine into clinic to curb fast-growing outbreak
文献与产业新闻评分1010 Cari-Anne Quinn: Turning possibility into progress – health innovation in Wales
文献与产业新闻评分2323 Osivax bags flu vaccine rights to pursue combination shot vision
文献与产业新闻评分2323 Artis BioSolutions expands synthetic DNA, mRNA production with Spanish facility
文献与产业新闻评分66 AbbVie's patient support extends to the classroom with immunology scholarship program
文献与产业新闻评分2828 Flagship’s ProFound partners with Gates Foundation in $35M preeclampsia target discovery pact
文献与产业新闻评分2323 STAT+: Pharmalittle: We’re reading about a GSK shingles shot, U.S. employers dropping GLP-1 coverage, and more